| Adjuvant chemotherapy for head and neck cancer |
| C Jacobs |
|
JCO Jul 1 1989: 823–826.
[PDF]
|
 |
| The reporting of clinical trials: counting is not easy |
| M Zelen |
|
JCO Jul 1 1989: 827–828.
[PDF]
|
|
|
Prognostic factors for chemotherapy response and survival using combination chemotherapy as initial treatment of advanced head and neck squamous cell cancer |
| |
F Cognetti, P Pinnaro, EM Ruggeri, P Carlini, A Perrino, FA Impiombato, F Calabresi, MG Chilelli, and D Giannarelli |
| |
JCO Jul 1 1989: 829–837.
[Abstract]
[PDF]
|
|
|
Neoadjuvant and adjuvant methotrexate, cisplatin, and fluorouracil in multimodal therapy of head and neck cancer |
| |
EE Vokes, WJ Moran, R Mick, RR Weichselbaum, and WR Panje |
| |
JCO Jul 1 1989: 838–845.
[Abstract]
[PDF]
|
|
|
Combined simultaneous cisplatin/fluorouracil chemotherapy and split course radiation in head and neck cancer |
| |
SG Taylor, 4th, AK Murthy, DD Caldarelli, JL Showel, K Kiel, KL Griem, BB Mittal, M Kies, JC Hutchinson, Jr, and LD Holinger |
| |
JCO Jul 1 1989: 846–856.
[Abstract]
[PDF]
|
|
|
Immunologic determinants of head and neck cancer response to induction chemotherapy |
| |
SP Schantz, HE Savage, T Racz, FJ Liu, BW Brown, RD Rossen, and WK Hong |
| |
JCO Jul 1 1989: 857–864.
[Abstract]
[PDF]
|
|
|
Therapy of metastatic carcinoid tumor and the malignant carcinoid syndrome with recombinant leukocyte A interferon |
| |
CG Moertel, J Rubin, and LK Kvols |
| |
JCO Jul 1 1989: 865–868.
[Abstract]
[PDF]
|
|
|
Recombinant interleukin-2 by continuous infusion and adoptive transfer of recombinant interleukin-2-activated cells in patients with advanced cancer |
| |
PA Paciucci, JF Holland, O Glidewell, and R Odchimar |
| |
JCO Jul 1 1989: 869–878.
[Abstract]
[PDF]
|
|
|
Six-year results of the Eastern Cooperative Oncology Group trial of observation versus CMFP versus CMFPT in postmenopausal patients with node-positive breast cancer |
| |
SG Taylor, 4th, MW Knuiman, LA Sleeper, JE Olson, DC Tormey, KW Gilchrist, G Falkson, SN Rosenthal, PP Carbone, and FJ Cummings |
| |
JCO Jul 1 1989: 879–889.
[Abstract]
[PDF]
|
|
|
Fluorouracil and high-dose leucovorin in previously treated patients with metastatic breast cancer |
| |
SM Swain, ME Lippman, EF Egan, JC Drake, SM Steinberg, and CJ Allegra |
| |
JCO Jul 1 1989: 890–899.
[Abstract]
[PDF]
|
|
|
Weekly alternating etoposide, methotrexate, and actinomycin/vincristine and cyclophosphamide chemotherapy for the treatment of CNS metastases of choriocarcinoma |
| |
GJ Rustin, ES Newlands, RH Begent, J Dent, and KD Bagshawe |
| |
JCO Jul 1 1989: 900–903.
[Abstract]
[PDF]
|
|
|
Phase II treatment of medulloblastoma and pineoblastoma with melphalan: clinical therapy based on experimental models of human medulloblastoma |
| |
HS Friedman, Schold , SCJr, MS Mahaley, Jr, OM Colvin, WJ Oakes, NA Vick, PC Burger, SH Bigner, M Borowitz, and EC Halperin |
| |
JCO Jul 1 1989: 904–911.
[Abstract]
[PDF]
|
|
|
Hypertension in long-term survivors of childhood renal cancers |
| |
AF Kantor, FP Li, AJ Janov, NJ Tarbell, and SE Sallan |
| |
JCO Jul 1 1989: 912–915.
[Abstract]
[PDF]
|
|
|
Primary chemotherapy of brain metastasis in small-cell lung cancer |
| |
JS Lee, WK Murphy, BS Glisson, HM Dhingra, PY Holoye, and WK Hong |
| |
JCO Jul 1 1989: 916–922.
[Abstract]
[PDF]
|
|
|
Lack of relationship between in vitro tumor cell growth and prognosis in extensive-stage small-cell lung cancer |
| |
HC Stevenson, AF Gazdar, RI Linnoila, EK Russell, HK Oie, SM Steinberg, and DC Ihde |
| |
JCO Jul 1 1989: 923–931.
[Abstract]
[PDF]
|
|
|
Dose-intensive chemotherapy in refractory germ cell cancer--a phase I/II trial of high-dose carboplatin and etoposide with autologous bone marrow transplantation |
| |
CR Nichols, G Tricot, SD Williams, K van Besien, PJ Loehrer, BJ Roth, L Akard, R Hoffman, R Goulet, and SN Wolff |
| |
JCO Jul 1 1989: 932–939.
[Abstract]
[PDF]
|
|
|
Raynaud's phenomenon in patients treated with cisplatin, vinblastine, and bleomycin for germ cell cancer: measurement of vasoconstrictor response to cold |
| |
SW Hansen and N Olsen |
| |
JCO Jul 1 1989: 940–942.
[Abstract]
[PDF]
|
|
|
Comparison of intermittent versus continuous infusion metoclopramide in control of acute nausea induced by cisplatin chemotherapy |
| |
RM Navari |
| |
JCO Jul 1 1989: 943–946.
[Abstract]
[PDF]
|
|
|
Cardiac morphologic and functional changes induced by epirubicin chemotherapy |
| |
MD Dardir, VJ Ferrans, YS Mikhael, MS el-Grindy, AB el-Aasar, HM el-Zawahry, DW Alling, SM Banks, and NG el-Mawla |
| |
JCO Jul 1 1989: 947–958.
[Abstract]
[PDF]
|
|
|
Measuring quality of life in cancer patients |
| |
K Donovan, RW Sanson-Fisher, and S Redman |
| |
JCO Jul 1 1989: 959–968.
[Abstract]
[PDF]
|
|
|
Analyzing the same data in two ways: a demonstration model to illustrate the reporting and misreporting of clinical trials |
| |
J Baar and I Tannock |
| |
JCO Jul 1 1989: 969–978.
[Abstract]
[PDF]
|
|
| Allogeneic bone marrow transplantation versus chemotherapy in first- remission acute myeloid leukemia |
| J Reiffers, MH Gaspard, D Maraninchi, and M Michallet |
|
JCO Jul 1 1989: 979–981.
[PDF]
|
|
| Therapy for lymphoma in the elderly |
| JE Radford, Jr and DH Vesole |
|
JCO Jul 1 1989: 981–983.
[PDF]
|
|
